Plasma creatine, estimated intramuscular creatine, transcellular gradient and the risk of mortality: Results from the PREVEND study
European Journal of Clinical Investigation · 2026
DOI: 10.1111/eci.70110 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Clinical Investigation, 2026. Verfasst von Caecilia S E Doorenbos und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands. Hauptthemen laut MEDLINE: Creatine, Muscle, Skeletal, Mortality. Die Arbeit nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Nierstichting, Hartstichting, Ausam.
Abstract (Originalsprache)
Background
Creatine, an endogenous compound essential for energy metabolism and cellular function, has been associated with numerous beneficial effects in sports and overall health. Here, we investigated relationships between plasma creatine concentration, estimated intramuscular creatine concentration, and all‐cause mortality in the general population.
Methods
In a Dutch prospective population‐based cohort, plasma creatine concentration, 24‐h urinary creatinine excretion and muscle mass (assessed with bio‐electrical impedance analysis) were measured in 5127 participants. Total creatine pool size, calculated from 24‐h creatinine excretion (assuming a 1.7% daily excretion of the total creatine pool), was divided by muscle mass to estimate intramuscular creatine concentrations. Transcellular gradient was calculated as intramuscular concentration divided by plasma concentration. Hazard ratios for mortality per doubling were assessed using multivariable Cox proportional hazard models, adjusting for common cardiovascular risk factors for mortality.
Results
Median plasma creatine concentrations were 41 [30–54] μmol/L in females and 28 [21–38] μmol/L in males. Mean intramuscular creatine concentrations were 30 ± 5.0 mmol/kg in females and 27.4 ± 5.0 mmol/kg in males. Median transcellular creatine gradients were 734 [550–1011] in females and 955 [715–1324] in males. Higher intramuscular creatine concentrations were associated with lower mortality in females (HR (95% CI) = .43 (.2; .66)); with a weaker trend in males (HR (95% CI) = .73 (.53; 1.02)). Plasma creatine concentrations were not associated with mortality.
Conclusion
Higher estimated intramuscular creatine concentrations are strongly associated with lower all‐cause mortality in females, with a weaker trend in males. Future research should explore causality, as well as further explore the remarkable sex difference.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
- Department of Primary and Long-Term Care, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
- Labcorp, Morrisville, North Carolina, USA.
ORCID-Profile: Caecilia S E Doorenbos, Adrian Post, Robin P F Dullaart
Förderung
- Nierstichting
- Hartstichting
- Ausam
- Roche
- Dade Behring
- Abbott Laboratories
Zitieren
APA
Doorenbos, C. S. E., Post, A., Stegmann, M. E., Franssen, C. F. M., Dullaart, R. P. F., Navis, G., Connelly, M. A., & Bakker, S. J. L. (2026). Plasma creatine, estimated intramuscular creatine, transcellular gradient and the risk of mortality: Results from the PREVEND study. European Journal of Clinical Investigation. https://doi.org/10.1111/eci.70110
Vancouver
Doorenbos CSE, Post A, Stegmann ME, Franssen CFM, Dullaart RPF, Navis G, et al. Plasma creatine, estimated intramuscular creatine, transcellular gradient and the risk of mortality: Results from the PREVEND study. European Journal of Clinical Investigation. 2026. doi:10.1111/eci.70110
BibTeX
@article{Doorenbos2026,
author = {Doorenbos, Caecilia S E and Post, Adrian and Stegmann, Mariken E and Franssen, Casper F M and Dullaart, Robin P F and Navis, Gerjan and Connelly, Margery A and Bakker, Stephan J L},
title = {Plasma creatine, estimated intramuscular creatine, transcellular gradient and the risk of mortality: Results from the PREVEND study},
journal = {European Journal of Clinical Investigation},
year = {2026},
doi = {10.1111/eci.70110}
}
EUVIMED